Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff S Isenberg

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Microsurgery|July 27, 2005
Nitric oxide in wound-healingJeff S Isenberg, Lisa A Ridnour, Michael Graham Espey, et al.
The Journal of Biological Chemistry|April 10, 2007
Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptakeJeff S Isenberg, Yifeng Jia, Julia Fukuyama, et al.
Surgery|December 17, 2008
Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signalingJeff S Isenberg, Justin B Maxhimer, Perlita Powers, et al.
The Journal of Biological Chemistry|October 7, 2010
Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47Sukhbir Kaur, Gema Martin-Manso, Michael L Pendrak, et al.
Annals of Surgery|April 29, 2008
Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human diseaseJeff S Isenberg, Martin J Romeo, Justin B Maxhimer, et al.
The Journal of Biological Chemistry|July 13, 2006
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1Jeff S Isenberg, Lisa A Ridnour, Julie Dimitry, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent mannerJeff S Isenberg, Lisa A Ridnour, Elizabeth M Perruccio, et al.
Free Radical Biology & Medicine|March 17, 2006
Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradientsJeff S Isenberg, Lisa A Ridnour, Douglas D Thomas, et al.
Neoplasia (New York, N.Y.)|August 2, 2008
Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flowJeff S Isenberg, Fuminori Hyodo, Lisa A Ridnour, et al.
The Journal of Biological Chemistry|November 14, 2008
Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responsesJeff S Isenberg, Douglas S Annis, Michael L Pendrak, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Microsurgery|July 27, 2005
Nitric oxide in wound-healingJeff S Isenberg, Lisa A Ridnour, Michael Graham Espey, et al.
The Journal of Biological Chemistry|April 10, 2007
Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptakeJeff S Isenberg, Yifeng Jia, Julia Fukuyama, et al.
Surgery|December 17, 2008
Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signalingJeff S Isenberg, Justin B Maxhimer, Perlita Powers, et al.
The Journal of Biological Chemistry|October 7, 2010
Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47Sukhbir Kaur, Gema Martin-Manso, Michael L Pendrak, et al.
Annals of Surgery|April 29, 2008
Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human diseaseJeff S Isenberg, Martin J Romeo, Justin B Maxhimer, et al.
The Journal of Biological Chemistry|July 13, 2006
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1Jeff S Isenberg, Lisa A Ridnour, Julie Dimitry, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent mannerJeff S Isenberg, Lisa A Ridnour, Elizabeth M Perruccio, et al.
Free Radical Biology & Medicine|March 17, 2006
Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradientsJeff S Isenberg, Lisa A Ridnour, Douglas D Thomas, et al.
Neoplasia (New York, N.Y.)|August 2, 2008
Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flowJeff S Isenberg, Fuminori Hyodo, Lisa A Ridnour, et al.
The Journal of Biological Chemistry|November 14, 2008
Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responsesJeff S Isenberg, Douglas S Annis, Michael L Pendrak, et al.
Pageof 4